Search research articles
Contact Us
Filters
Showing results (81-90 of 102) with videos related to
Page
of 11
Sort By:
Pediatric Research
|
March 18, 2020
Fixing the leaky pipeline: identifying solutions for improving pediatrician-scientist training during pediatric residency
Audrea M Burns, Kate G Ackerman, Satid Thammasitboon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2025
Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology Group
Florette K Hazard, Angus M S Toland, Serena Y Tan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 15, 2021
Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Ronald S Go, Eric Jacobsen, Robert Baiocchi, et al.
Transplantation and Cellular Therapy
|
April 6, 2021
Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1
M Meaghan Granger, Arlene Naranjo, Rochelle Bagatell, et al.
Nature Genetics
|
April 14, 2025
Longitudinal single-cell multiomic atlas of high-risk neuroblastoma reveals chemotherapy-induced tumor microenvironment rewiring
Wenbao Yu, Rumeysa Biyik-Sit, Yasin Uzun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 2011
miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples
Katleen De Preter, Pieter Mestdagh, Joëlle Vermeulen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2017
Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group
Amy K Erbe, Wei Wang, Lakeesha Carmichael, et al.
JCI Insight
|
December 7, 2018
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients
Fjoralba Zeka, Anneleen Decock, Alan Van Goethem, et al.
Cell Reports
|
November 1, 2018
TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast Cancer
Robert M Witwicki, Muhammad B Ekram, Xintao Qiu, et al.
Journal of the National Cancer Institute
|
March 8, 2018
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
Pauline Depuydt, Valentina Boeva, Toby D Hocking, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 102) with videos related to
Sort By:
Page
of 11
Pediatric Research
|
March 18, 2020
Fixing the leaky pipeline: identifying solutions for improving pediatrician-scientist training during pediatric residency
Audrea M Burns, Kate G Ackerman, Satid Thammasitboon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2025
Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology Group
Florette K Hazard, Angus M S Toland, Serena Y Tan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 15, 2021
Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Ronald S Go, Eric Jacobsen, Robert Baiocchi, et al.
Transplantation and Cellular Therapy
|
April 6, 2021
Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1
M Meaghan Granger, Arlene Naranjo, Rochelle Bagatell, et al.
Nature Genetics
|
April 14, 2025
Longitudinal single-cell multiomic atlas of high-risk neuroblastoma reveals chemotherapy-induced tumor microenvironment rewiring
Wenbao Yu, Rumeysa Biyik-Sit, Yasin Uzun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 2011
miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples
Katleen De Preter, Pieter Mestdagh, Joëlle Vermeulen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2017
Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group
Amy K Erbe, Wei Wang, Lakeesha Carmichael, et al.
JCI Insight
|
December 7, 2018
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients
Fjoralba Zeka, Anneleen Decock, Alan Van Goethem, et al.
Cell Reports
|
November 1, 2018
TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast Cancer
Robert M Witwicki, Muhammad B Ekram, Xintao Qiu, et al.
Journal of the National Cancer Institute
|
March 8, 2018
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
Pauline Depuydt, Valentina Boeva, Toby D Hocking, et al.
Page
of 11